Key takeaways StormX (STMX), one of the first global crypto-based solutions to reach international markets, managed to ...

Beta Bionics (NASDAQ:BBNX) stock was inititaed by Baird with a Neutral rating, citing valuation concerns but highlighting the ...

Northcoast analyst Keith Housum downgraded Axon (AXON) to Neutral from Buy, stating that Axon’s “partner turned competitor” is “turning into a ...

Australia's central bank expects underlying inflation to fall faster than previously expected as it downgraded the economic ...

RAPT Therapeutics pivoted from a failed inflammation asset (RPT193) to focus on RPT904 for food allergies. Find out whether ...

"Retail has to remember, things go up fast and they go down fast. Take your profits and don't be greedy," an investor from ...

UBS analyst Matthew Weston downgraded Novartis (NVS) to Neutral from Buy with a price target of CHF 104, down from CHF 111. The firm believes ...

Research reports from Morningstar & Argus help you make better investment decisions. Leverage these to understand future stock performance and identify high performing investment ideas. You can ...

Following explosive gains in Friday's trading, Cloudflare stock is seeing continued bullish momentum thanks to coverage from analysts. Before the market opened this morning, Mizuho and Susquehanna ...

Mobileye stock surges after BofA analyst upgrades it to Neutral and raises price target from $12 to $19 due to potential ...